Abstract
Striatal dopaminergic overactivity was hypothesized as the core pathophysiology of schizophrenia. However, morphological alterations of striatum in schizophrenia remains exclusive, largely because brain regional heterogeneity limited traditional group-mean based approach. Leveraging third-party brain maps of neurotransmitter and cognition behaviours, we developed a pattern-based representation feature score (ReFS) to investigate structural spatial pattern variation in schizophrenia. Structural ReFS of subcortical regions, particularly the striatum, were linked to schizophrenia diagnosis, symptom severity, and genetic susceptibility. Dopaminergic-ReFS of striatum was increased in schizophrenia patients and reliably reproduced across 13 datasets. The pattern-based ReFS effectively captured the shared genetic pathways underlying both schizophrenia and striatum. The results provide convergent, multimodal suggest the central role of striatal spatial patterns in schizophrenia psychopathologies and and open new avenues to develop individualized treatments for psychotic disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work received support from the following sources: the National Natural Science Foundation of China (T2122005 [to TJ], 82150710554 [to GS], KRH2306051 [CX] and 81801773 [to TJ]), China Postdoctoral Science Foundation (no. BX20230075 and 2023M740659 to CX). MOE Frontiers Center for Brain Science [to CX], National Key R and D Program of China (2023ZY1068 [to TJ], 2019YFA0709501 [to TJ], 2021YFC2501402 [to TJ], 2019YFA0709502 [to JF], 2018YFC1312900 [to TJ] and 2018YFC1312904 [to JF]), the Shanghai Pujiang Project (18PJ1400900 [to TJ]), Guangdong Key Research and Development Project (No. 2018B030335001 [to JF]), the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behavior in normal brain function and psychopathology) (LSHM-CT-2007-037286 [to GS]), the Horizon 2020-funded ERC Advanced Grant' STRATIFY' (Brain network based stratification of reinforcement-related disorders) (695313 [to GS]), the 111 Project (B18015 [to JF]), the key project of Shanghai Science and Technology (16JC1420402 [to JF]), Shanghai Municipal Science and Technology Major Project (no. 2018SHZDZX01 [to JF]), ZJ Lab [to JF], Shanghai Center for Brain Science and Brain-Inspired Technology [to JF], ERANID (Understanding the Interplay between Cultural, Biological and Subjective Factors in Drug Use Pathways) (PR-ST-0416-10004, [to GS]), Human Brain Project (HBP SGA 2, 785907, and HBP SGA 3, 945539, [to GS]), the Medical Research Council Grant' c-VEDA' (Consortium on Vulnerability to Externalising Disorders and Addictions) (MR/N000390/1 [to GS]), the National Institute of Health (NIH) (R01DA049238, A decentralised macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers [to GS]), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, the Bundesministeriumfur Bildung und Forschung (BMBF grants 01GS08152; 01EV0711 [to GS]; the European Union and UKRI funded project environMENTAL (grants 101057429 [to GS]). Forschungsnetz AERIAL 01EE1406A, 01EE1406B [to GS]), Forschungsnetz IMAC-Mind 01GL1745B [to GS]), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2, SFB 940, TRR 265, NE 1383/14-1, [to GS]).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
